1 1128 175 EFFICACY OF VAMANA KARMA WITH IKSHVAKU KSHEERA YOGA IN THE MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA). INTRODUCTION: BRONCHIAL ASTHMA IS A HIGHLY PREVALENT DISEASE, AND IN MOST OF THE ETIOPATHOGENESIS AND SYMPTOMATOLOGY, IT CAN BE CORRELATED WITH TAMAKA SHVASA. IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY.) IS AN ANNUAL HERBACEOUS CLIMBING PLANT WITH A LONG HISTORY OF MEDICINAL USES FOR THE TREATMENT OF VARIOUS AILMENTS INCLUDING JAUNDICE, DIABETES, ULCER, PILES, COLITIS, ASTHMA, INSANITY, HYPERTENSION, CONGESTIVE CARDIAC FAILURE AND SKIN DISORDERS. ITS FRUIT PULP IS USED BOTH AS AN EMETIC AND AS A PURGATIVE. AIMS: TO STUDY THE EFFICACY OF VAMANA KARMA WITH IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY) KSHEERA YOGA. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA FOR BRONCHIAL ASTHMA WERE SELECTED FROM OUTPATIENT AND INPATIENT DEPARTMENT OF PANCHAKARMA DEPARTMENT. THE SIGN AND SYMPTOMS, MAINLY BREATHLESSNESS, COUGH AND RHONCHI WERE GIVEN SCORES DEPENDING ON THEIR SEVERITY. THE PATIENTS WERE ALSO ASSESSED FOR LUNG FUNCTION TEST TO DETERMINE PULMONARY IMPAIRMENT. FOR VAMANA, THEY WERE GIVEN DEEPANA AND PACHANA WITH TRIKATU CHURNA FOR 3 DAYS AND THEN THEY WERE SUBJECTED TO SNEHAPANA WITH LUKEWARM COW'S GHEE. AFTER THE COMPLETION OF SNEHAPANA, THE PATIENT WERE GIVEN ABHYANGA, VASHPA SWEDANA AND DIET WITH PREDOMINANCE OF KAPHA (KAPHA BAHULA AHARA- DIET MIXED WITH MILK OR CURD), WHICH WAS THEN FOLLOWED BY VAMANA WITH IKSHVAKU KSHEERA YOGA AND SAMSARJANA KRAMA. FOLLOW-UP WAS DONE AT AN INTERVAL OF 15 DAYS FOR THREE TIMES AND T SCORES WERE NOTED BEFORE AND AFTER THE TREATMENT. THE SCORES WERE ANALYZED USING WILCOXON SIGNED-RANK TEST FOR SUBJECTIVE PARAMETERS AND STUDENT'S PAIRED T-TEST FOR OBJECTIVE PARAMETERS. RESULTS: THE TRIAL DRUG HAS SHOWN STATISTICALLY HIGHLY SIGNIFICANT REDUCTION IN BREATHLESSNESS, COUGH, RHONCHI, AND SIGNIFICANT CHANGES IN LUNG FUNCTION TESTS. CONCLUSION: THE TEST DRUG PROVED ITS EMETIC EFFECT ON THE PATIENTS OF BRONCHIAL ASTHMA AND THUS RELIEVED THE SYMPTOMS OF THE DISEASE IMMEDIATELY. IT HAS REDUCED FREQUENCY OF EPISODES OF BREATHLESSNESS AND SEVERITY OF SYMPTOMS. 2017 2 489 40 CLINICAL STUDY ON THE EFFICACY OF RAJAYAPANA BASTI AND BALADI YOGA IN MOTOR DISABILITIES OF CEREBRAL PALSY IN CHILDREN. BACKGROUND: CEREBRAL PALSY IS A STATIC ENCEPHALOPATHY THAT MAY BE DEFINED AS A NON-PROGRESSIVE DISORDER OF POSTURE AND MOVEMENT OFTEN ASSOCIATED WITH EPILEPSY AND ABNORMALITIES IN SPEECH, VISION AND INTELLECT RESULTING FROM A DEFECT OR LESION OF THE DEVELOPING BRAIN. THERE ARE 25 LAKHS CEREBRAL PALSY AFFECTED CHILDREN IN INDIA. AIM: TO ASSESS THE EFFICACY OF RAJAYAPANA BASTI (RB) AND BALADI YOGA IN MOTOR DISABILITIES OF CEREBRAL PALSY IN CHILDREN. MATERIALS AND METHODS: TOTAL 98 CHILDREN SATISFYING DIAGNOSTIC CRITERIA AND BETWEEN THE AGE GROUP OF 2-10 YEARS WERE INCLUDED AND RANDOMLY DIVIDED INTO TWO GROUPS. IN RB WITH BALADI GROUP (N = 40) PATIENTS WERE TREATED WITH MUSTADI RAJAYAPANA BASTI FOR 8 DAYS, FOLLOWED BY ORAL ADMINISTRATION OF BALADI YOGA WITH HONEY AND GHEE FOR 60 DAYS. BEFORE ADMINISTERING BASTI, PATIENTS WERE SUBJECTED TO SARVANGA ABHYANGA AND SASTIKASHALI PINDA SVEDA. IN THE CONTROL GROUP (N = 40), PATIENTS WERE GIVEN TABLETS OF GODHUMA CHOORNA FOR 60 DAYS. BEFORE ADMINISTERING THE PLACEBO TABLET, THE PATIENTS OF THE CONTROL GROUP WERE GIVEN SARVANGA ABHYANGA AND SASTIKASHALI PINDA SVEDA FOR 8 DAYS. THE PATIENTS OF THE CONTROL GROUP WERE GIVEN BASTI WITH LUKEWARM WATER FOR 8 DAYS. RESULTS: RB GROUP HAS SHOWN IMPROVEMENTS IN UNDERSTANDING ABILITY (13.43%), SPEECH (10%) AND PERFORMANCE SKILL (11.11%), IN FINE MOTOR FUNCTIONS SUCH AS PUTTING SMALL OBJECT IN TO A CONTAINER (14.3%), THROWS THE BALL IN ALL DIRECTION (21.8%), USE OF THUMB AND INDEX FINGER (10.93%), RETAINING 2 INCH CUBE IN FIST (19.04%), FOLDS PAPER AND INSERTS INTO ENVELOPE (10.30%), IN GROSS MOTOR FUNCTIONS SUCH AS IN CRAWLING (26.7%), SITTING (31.7%), STANDING (13.75%), WALKING (9.5%) AND CLAPS HANDS (13.9%) RESPECTIVELY. CONCLUSION: MUSTADI RB ALONG WITH BALADI YOGA PROVIDED A SIGNIFICANT IMPROVEMENT IN ALL THE PARAMETERS AND HAS PROMISING RESULT IN MANAGING MOTOR DISABILITIES OF CEREBRAL PALSY IN CHILDREN. 2014 3 483 54 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 4 689 41 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 5 496 30 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018 6 2283 47 THE USE OF INTEGRATIVE THERAPY BASED ON YOGA AND AYURVEDA IN THE TREATMENT OF A HIGH-RISK CASE OF COVID-19/SARS-COV-2 WITH MULTIPLE COMORBIDITIES: A CASE REPORT. BACKGROUND: WE REPORT A HIGH-RISK CASE OF A CORONAVIRUS DISEASE 19 (COVID-19)-POSITIVE PATIENT WITH COMORBIDITIES INCLUDING DIABETES MELLITUS (DM), HYPERTENSION (HTN), HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE (CKD), TREATED SUCCESSFULLY USING AN INTEGRATIVE THERAPY PLAN BASED ON AYURVEDA AND YOGA, ALONG WITH GOVERNMENT-MANDATED COMPULSORY MODERN WESTERN MEDICINE (MWM) TREATMENT. RECENTLY, SOME EVIDENCE HAS BEEN EMERGING ON THE USE OF AYURVEDA FOR TREATMENT OF COVID-19. THE CLASSICAL TEXTS OF AYURVEDIC MEDICINE SUCH AS CHARAKA SAMHITA AND SUSHRUTA SAMHITA CONTAIN DESCRIPTIONS OF PANDEMICS OF SIMILAR PROPORTIONS AND DESCRIBE THEM AS JANAPADODDHVANSA, MEANING THE DESTRUCTION OF COMMUNITIES, ALONG WITH THEIR CAUSES AND TREATMENT. CASE PRESENTATION: THE CASE REPORTED HEREIN IS A 55-YEAR-OLD MAN FROM DELHI, INDIA, WITH CONFIRMED (TESTED) COVID-19, WHO FIRST TOOK MWM FOR 7 DAYS BEFORE SEEKING INTEGRATIVE THERAPY. THE PATIENT HAS COMORBIDITIES INCLUDING DM, HTN, HYPOTHYROIDISM AND CKD AND HAD DEVELOPED SYMPTOMS INCLUDING FEVER (WHICH WAS RESOLVED BY THE TIME INTEGRATIVE THERAPY WAS STARTED), SORE THROAT, DRY COUGH, BODY ACHES, WEAKNESS, BAD TASTE AND SMELL, AND HEAVINESS IN THE ABDOMEN. BASED ON THE PATIENT'S SYMPTOMS AND COMORBIDITIES, A TREATMENT PLAN INCLUDING AYURVEDIC MEDICINES, YOGA PROTOCOL, DIETARY RECOMMENDATIONS AND LIFESTYLE MODIFICATIONS WAS PRESCRIBED BY A REGISTERED AYURVEDA DOCTOR AND A YOGA CONSULTANT. THE PATIENT STARTED EXPERIENCING IMPROVEMENT IN ALL THE SYMPTOMS WITHIN 2 DAYS AFTER STARTING THE TREATMENT; HE REPORTED APPROXIMATELY [FORMULA: SEE TEXT] RELIEF FROM THE SYMPTOMS AFTER 5 DAYS, AND ALMOST COMPLETE RELIEF WITHIN 9 DAYS. ALSO, THE BLOOD SUGAR LEVELS (BOTH FASTING BLOOD SUGAR [FBS] AND POSTPRANDIAL BLOOD SUGAR [PPBS]) EXHIBITED SIGNIFICANT IMPROVEMENT AFTER 5 DAYS, AND DECREASED TO WITHIN THE NORMAL RANGE WITHIN 12 DAYS. BESIDES RELIEF IN SYMPTOMS, THE PATIENT'S REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) TEST DONE ON THE 19TH DAY RETURNED NEGATIVE RESULTS. CONCLUSIONS: INTEGRATIVE THERAPY WAS FOUND TO BE EFFECTIVE IN MITIGATING THE SYMPTOMS OF COVID-19 IN THIS PATIENT WITH MULTIPLE COMORBIDITIES. MOREOVER, A SIGNIFICANT IMPROVEMENT IN BLOOD SUGAR LEVELS (NOT UNDER CONTROL WITH MODERN MEDICINE) WAS ALSO ACHIEVED. INTEGRATIVE THERAPY BASED ON THE CLASSICAL TEXTS OF AYURVEDA AND YOGA MAY OFFER A PROMISING AND SCALABLE TREATMENT OPTION FOR COVID-19 PATIENTS. A CASE SERIES OR A SUITABLY DESIGNED RANDOMIZED CONTROLLED TRIAL IS NEEDED TO ASSESS ITS EFFICACY. 2021 7 959 26 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 8 867 60 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 9 1374 38 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 10 660 40 EFFECT OF 12 WEEKS OF YOGA THERAPY ON QUALITY OF LIFE AND INDIAN DIABETES RISK SCORE IN NORMOTENSIVE INDIAN YOUNG ADULT PREDIABETICS AND DIABETICS: RANDOMIZED CONTROL TRIAL. INTRODUCTION: INDIA HAS BECOME THE EPICENTRE FOR DIABETES, A STRESS-RELATED DISORDER AFFECTING THE WORKING SKILLS AND DAY-TO-DAY LIFESTYLE MANAGEMENT OF YOUNGER POPULATION. MOST OF THE STUDIES HAVE REPORTED THE EFFECT OF YOGA ON IMPROVING QUALITY OF LIFE (QOL) IN DIABETIC PATIENTS WITH OTHER COMORBIDITIES. TILL DATE, NO RANDOMIZED CONTROL TRIAL REPORTS ARE AVAILABLE TO SHOW THE EFFECT OF YOGA THERAPY ON QOL AND INDIAN DIABETES RISK SCORE (IDRS) IN NORMOTENSIVE PREDIABETIC AND DIABETIC YOUNG INDIVIDUALS. AIM: TO DETERMINE THE EFFECT OF 12 WEEKS OF YOGA THERAPY ON QOL AND IDRS AMONG NORMOTENSIVE PREDIABETIC AND DIABETIC YOUNG INDIAN ADULTS. MATERIALS AND METHODS: A RANDOMIZED CONTROL TRIAL WAS CONDUCTED IN ENDOCRINOLOGY OUTPATIENT DEPARTMENT (OPD). NORMOTENSIVE PARTICIPANTS (N=310) AGED 18-45 YEARS WERE DIVIDED INTO HEALTHY CONTROLS (N=62), PREDIABETICS (N=124) AND DIABETICS (N=124). STUDY GROUP SUBJECTS WERE RANDOMLY ASSIGNED TO GROUP II (N=62, PREDIABETES-STANDARD TREATMENT), GROUP III (N=62, PREDIABETES-STANDARD TREATMENT + YOGA THERAPY), GROUP IV (N=62, DIABETES-STANDARD TREATMENT) AND GROUP V (N=62, DIABETES-STANDARD TREATMENT + YOGA THERAPY). FLANAGAN QOL SCALE, IDRS QUESTIONNAIRE, FASTING PLASMA GLUCOSE (FPG) AND INSULIN WERE ASSESSED PRE AND POST 12 WEEKS OF INTERVENTION. STATISTICAL ANALYSIS WAS DONE USING STUDENT'S PAIRED T-TEST AND ONE-WAY ANOVA. RESULTS: PRE-POST INTERVENTION ANALYSIS SHOWED SIGNIFICANT IMPROVEMENT IN QOL SCALE WITH P<0.01 IN GROUP II AND GROUP IV; P<0.001 IN GROUP III AND GROUP V RESPECTIVELY. THERE WAS SIGNIFICANT REDUCTION IN IDRS IN GROUP II (P<0.05); P<0.001 IN GROUP III, GROUP IV AND GROUP V RESPECTIVELY. SIGNIFICANT DIFFERENCE (P<0.001) IN QOL SCALE AND IDRS WERE FOUND WHEN STUDY GROUPS WITH STANDARD TREATMENT ALONG WITH YOGA THERAPY WERE COMPARED TO STANDARD TREATMENT ALONE. CONCLUSION: YOGA THERAPY ALONG WITH STANDARD TREATMENT FOR 12 WEEKS IMPROVED QOL AND ATTENUATED THE DIABETES RISK AMONG INDIAN PREDIABETICS AND DIABETICS COMPARED TO STANDARD TREATMENT ALONE. 2017 11 2885 51 YOGA: AS AN ADJUNCT THERAPY TO TRIM DOWN THE AYURVEDIC DRUG REQUIREMENT IN NON INSULIN-DEPENDENT DIABETES MELLITUS. INTRODUCTION: IN SPITE OF A LARGE NUMBER OF DRUGS SHOWING ANTI-HYPERGLYCEMIC ACTIVITIES, NONE OF THEM HAVE BEEN SUCCESSFUL IN COMPLETE MANAGEMENT OF DIABETES MELLITUS (DM). YOGA AND AYURVEDA ARE THE TWO SCHOOLS OF THOUGHT IN INDIA, WHICH HAVE A HISTORY OF CURING DISEASES SINCE THOUSANDS OF YEARS. YOGIC TECHNIQUES AND AYURVEDIC HERBS HAVE PROVEN THEIR ANTI-DIABETIC POTENTIAL WITHOUT INDUCING UNTOWARD EFFECTS. THE PRESENT STUDY COMBINES AYURVEDIC MEDICATION WITH YOGA TECHNIQUES AS A NEW APPROACH TOWARD HEALING DM. AIMS AND OBJECTIVES: TO ASSESS THE EFFECT OF YOGA THERAPY IN THE MANAGEMENT OF NON INSULIN-DEPENDENT DM (NIDDM) AND TO DECREASE THE ORAL DRUG DOSE REQUIREMENT OF GUDUCI GHANA TABLET. MATERIALS AND METHODS: THIRTY KNOWN NIDDM PATIENTS OF BOTH GENDERS, WHO WERE ON GUDUCI GHANA (SOLIDIFIED AQUEOUS EXTRACT OF TINOSPORA CORDIFOLIA (WILLD.) MIERS.) TABLETS FROM PAST 2 MONTHS AS AYURVEDIC REMEDY FOR DM WERE SELECTED. ALONG WITH GUDUCI GHANA ADMINISTRATION, THE SUBJECTS WERE INSTRUCTED TO FOLLOW YOGIC PROCEDURES INCLUDING ASANAS, PRANAYAMA, AND SUDDHI KRIYAS. THE STUDY WAS CONDUCTED FOR 8 WEEKS, WHEREIN FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS ALONG WITH RELIEF IN SIGN AND SYMPTOMS WERE ASSESSED AT EVERY 2 WEEKS INTERVALS, AND ACCORDING TO RELIEF IN SIGN AND SYMPTOMS, TAPERING OF DRUG DOSAGE WAS CARRIED OUT. THE OBTAINED DATA WERE ANALYZED STATISTICALLY BY APPLYING PAIRED T-TEST. RESULTS AND CONCLUSION: THE RESULTS OBTAINED WERE PROMISING AS THE RELIEF IN DIABETIC SYMPTOMATOLOGY WAS HIGHLY SIGNIFICANT IN TERMS OF P VALUE. 80.83% REDUCTION IN DOSE OF GUDUCI GHANA TABLETS AND 7.85% AND 8.78% FALL IN FBS AND PPBS LEVELS, RESPECTIVELY, AFTER THE COMPLETE COURSE OF TREATMENT. THE OBTAINED P VALUE SHOWED HIGHLY SIGNIFICANT RESULTS. 2014 12 904 50 EFFECTIVENESS OF ADJUVANT YOGA THERAPY IN DIABETIC LUNG: A RANDOMIZED CONTROL TRIAL. CONTEXT: RECENT STUDIES PROVIDE AMPLE EVIDENCE OF THE BENEFITS OF YOGA IN VARIOUS CHRONIC DISORDERS. DIABETES MELLITUS IS A GROUP OF METABOLIC DISEASES CHARACTERIZED BY CHRONIC HYPERGLYCEMIA AND SANDLER COINED THE TERM "DIABETIC LUNG" FOR THE ABNORMAL PULMONARY FUNCTION DETECTED IN DIABETIC PATIENTS DUE UNDERLYING PULMONARY DYSFUNCTION. YOGA THERAPY MAY HELP IN ACHIEVING BETTER PULMONARY FUNCTION ALONG WITH ENHANCED GLYCAEMIC CONTROL AND OVERALL HEALTH BENEFITS. AIM: TO STUDY THE EFFECT OF ADJUVANT YOGA THERAPY IN DIABETIC LUNG THROUGH SPIROMETRY. SETTINGS AND DESIGN: RANDOMIZED CONTROL TRIAL WAS MADE AS INTERDISCIPLINARY COLLABORATIVE WORK BETWEEN DEPARTMENTS OF YOGA THERAPY, PULMONARY MEDICINE AND ENDOCRINOLOGY, OF MGMC & RI, SRI BALAJI VIDYAPEETH PUDUCHERRY. MATERIALS AND METHODS: 72 PATIENTS OF DIABETIC LUNG AS CONFIRMED BY SPIROMETRY (<70% OF EXPECTED) WERE RANDOMIZED INTO CONTROL GROUP (N=36) WHO RECEIVED ONLY STANDARD MEDICAL TREATMENT AND YOGA GROUP (N=36) WHO RECEIVED YOGA TRAINING THRICE WEEKLY FOR 4 MONTHS ALONG WITH STANDARD MEDICAL MANAGEMENT. YOGA THERAPY PROTOCOL INCLUDED YOGIC COUNSELING, PREPARATORY PRACTICES, ASANAS OR STATIC POSTURES, PRANAYAMA OR BREATHING TECHNIQUES AND RELAXATION TECHNIQUES. HATHENAS OF THE GITANANDA YOGA TRADITION WERE THE MAIN PRACTICES USED. SPIROMETRY WAS DONE AT THE END OF THE STUDY PERIOD. DATA WAS ANALYZED BY STUDENT'S PAIRED AND UNPAIRED 'T' TEST AS IT PASSED NORMALITY. RESULTS: THERE WAS A STATISTICALLY SIGNIFICANT (P < 0.05) REDUCTION IN WEIGHT, AND BMI ALONG WITH A SIGNIFICANT (P < 0.01) IMPROVEMENT IN PULMONARY FUNCTION (FEV1, FVC) IN YOGA GROUP AS COMPARED TO CONTROL GROUP WHERE PARAMETERS WORSENED OVER STUDY PERIOD. CONCLUSION: IT IS CONCLUDED FROM THE PRESENT RCT THAT YOGA HAS A DEFINITE ROLE AS AN ADJUVANT THERAPY AS IT ENHANCES STANDARD MEDICAL CARE AND HENCE IS EVEN MORE SIGNIFICANT IN ROUTINE CLINICAL MANAGEMENT OF DIABETES, IMPROVING PHYSICAL CONDITION AND PULMONARY FUNCTION. 2019 13 1453 28 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 14 453 35 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 15 691 40 EFFECT OF COMMUNITY-BASED STRUCTURED YOGA PROGRAM ON HBA1C LEVEL AMONG TYPE 2 DIABETES MELLITUS PATIENTS: AN INTERVENTIONAL STUDY. CONTEXT: IN VIEW OF THE RISING BURDEN OF TYPE 2 DIABETES MELLITUS (DM) CASES IN INDIA, THERE IS AN URGENT NEED FOR AN EFFECTIVE, LOW-COST, SUSTAINABLE INTERVENTION CONTROLLING DIABETES THUS PREVENTING COMPLICATIONS. AIMS: THIS STUDY AIMED TO ASSESS THE EFFECT OF STRUCTURED YOGA PROGRAMS ON DIABETES. SUBJECTS AND METHODS: THIS WAS A COMMUNITY-BASED INTERVENTIONAL STUDY THAT WAS CONDUCTED IN AN URBAN RESETTLEMENT COLONY OF DELHI, INDIA. KNOWN DIABETES PATIENTS WITH GLYCATED HEMOGLOBIN (HB1AC) >/=6.5% WERE ENROLLED FROM 12 RANDOMLY SELECTED BLOCKS OF THE COMMUNITY WITH A SAMPLE SIZE OF 192 IN EACH INTERVENTION AND WAIT-LISTED CONTROL ARM. THE INTERVENTION WAS STRUCTURED YOGA OF 50 MIN DAILY, 2 CONSECUTIVE WEEKS IN A NEARBY PARK AND HEALTH CENTER FOLLOWED BY TWICE A WEEK HOME PRACTICE UP TO THE 3(RD) MONTH. THE PRIMARY OUTCOME MEASURE WAS HBA1C% AND SECONDARY OUTCOME MEASURES WERE LIPID PROFILE AND FASTING BLOOD GLUCOSE. STATISTICAL ANALYSIS USED: APER-PROTOCOL ANALYSIS WAS DONE. MEAN, STANDARD DEVIATION (SD), AND 95% CONFIDENCE INTERVAL WERE ESTIMATED. THE LEVEL OF SIGNIFICANCE WAS CONSIDERED FOR 0.05. RESULTS: THERE WAS A SIGNIFICANT DECREASE OF HB1AC (0.5%, SD = 1.5, P = 0.02), TOTAL CHOLESTEROL (11.7 MG/DL, SD = 40.5, P < 0.01), AND LOW-DENSITY LIPOPROTEIN (3.2 MG/DL, SD = 37.4, P < 0.01) FROM BASELINE TO END LINE IN THE INTERVENTION GROUP. THESE CHANGES IN INTERVENTION GROUP WERE ALSO SIGNIFICANTLY DIFFERENT FROM THE CHANGE IN THE WAIT-LISTED CONTROL GROUP. THE OTHER VARIABLES DID NOT CHANGE SIGNIFICANTLY. CONCLUSIONS: IT REVEALED THAT STRUCTURED YOGA PROGRAM IMPROVED GLYCEMIC OUTCOME AND LIPID PROFILE OF INDIVIDUALS IN A COMMUNITY-BASED SETTING. YOGA CAN BE A FEASIBLE STRATEGY TO CONTROL HYPERGLYCEMIA, LIPID LEVELS, AND CAN HELP BETTER CONTROL TYPE 2 DM. 2021 16 1261 40 FINGER DEXTERITY AND VISUAL DISCRIMINATION FOLLOWING TWO YOGA BREATHING PRACTICES. BACKGROUND: PRACTICING YOGA HAS BEEN SHOWN TO IMPROVE MOTOR FUNCTIONS AND ATTENTION. THOUGH ATTENTION IS REQUIRED FOR FINE MOTOR AND DISCRIMINATION TASKS, THE EFFECT OF YOGA BREATHING TECHNIQUES ON FINE MOTOR SKILLS AND VISUAL DISCRIMINATION HAS NOT BEEN ASSESSED. AIM: TO STUDY THE EFFECT OF YOGA BREATHING TECHNIQUES ON FINGER DEXTERITY AND VISUAL DISCRIMINATION. MATERIALS AND METHODS: THE PRESENT STUDY CONSISTED OF ONE HUNDRED AND FORTY SUBJECTS WHO HAD ENROLLED FOR STRESS MANAGEMENT. THEY WERE RANDOMLY DIVIDED INTO TWO GROUPS, ONE GROUP PRACTICED HIGH FREQUENCY YOGA BREATHING WHILE THE OTHER GROUP PRACTICED BREATH AWARENESS. HIGH FREQUENCY YOGA BREATHING (KAPALABHATI, BREATH RATE 1.0 HZ) AND BREATH AWARENESS ARE TWO YOGA PRACTICES WHICH IMPROVE ATTENTION. THE IMMEDIATE EFFECT OF HIGH FREQUENCY YOGA BREATHING AND BREATH AWARENESS (I) WERE ASSESSED ON THE PERFORMANCE ON THE O'CONNOR FINGER DEXTERITY TASK AND (II) (IN) A SHAPE AND SIZE DISCRIMINATION TASK. RESULTS: THERE WAS A SIGNIFICANT IMPROVEMENT IN THE FINGER DEXTERITY TASK BY 19% AFTER KAPALABHATI AND 9% AFTER BREATH AWARENESS (P<0.001 IN BOTH CASES, REPEATED MEASURES ANOVA AND POST-HOC ANALYSES). THERE WAS A SIGNIFICANT REDUCTION (P<0.001) IN ERROR (41% AFTER KAPALABHATI AND 21% AFTER BREATH AWARENESS) AS WELL AS TIME TAKEN TO COMPLETE THE SHAPE AND SIZE DISCRIMINATION TEST (15% AFTER KAPALABHATI AND 15% AFTER BREATH AWARENESS; P<0.001) WAS ALSO OBSERVED. CONCLUSION: BOTH KAPALABAHATI AND BREATH AWARENESS CAN IMPROVE FINE MOTOR SKILLS AND VISUAL DISCRIMINATION, WITH A GREATER MAGNITUDE OF CHANGE AFTER KAPALABHATI. 2012 17 779 39 EFFECT OF YOGA AS ADD-ON THERAPY IN MIGRAINE (CONTAIN): A RANDOMIZED CLINICAL TRIAL. OBJECTIVE: TO EVALUATE THE EFFECTIVENESS OF YOGA AS AN ADJUVANT TO CONVENTIONAL MEDICAL MANAGEMENT ON CLINICAL OUTCOMES IN PATIENTS WITH MIGRAINE. METHODS: CONTAIN WAS A PROSPECTIVE, RANDOMIZED, OPEN-LABEL SUPERIORITY TRIAL WITH BLINDED ENDPOINT ASSESSMENT CARRIED OUT AT A SINGLE TERTIARY CARE ACADEMIC HOSPITAL IN NEW DELHI, INDIA. PATIENTS ENROLLED WERE AGED 18-50 YEARS WITH A DIAGNOSIS OF EPISODIC MIGRAINE AND WERE RANDOMIZED INTO MEDICAL AND YOGA GROUPS (1:1). RANDOMIZATION WAS COMPUTER-GENERATED WITH A VARIABLE BLOCK SIZE AND CONCEALED. A PREDESIGNED YOGA INTERVENTION WAS GIVEN FOR 3 MONTHS. OUTCOMES WERE RECORDED BY A BLINDED ASSESSOR. THE PRIMARY ENDPOINT WAS A DECREASE IN HEADACHE FREQUENCY, HEADACHE INTENSITY, AND HEADACHE IMPACT TEST (HIT)-6 SCORE. SECONDARY OUTCOMES INCLUDED CHANGE IN MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORE, PILL COUNT, AND PROPORTION OF HEADACHE FREE PATIENTS. RESULTS: BETWEEN APRIL 2017 AND AUGUST 2018, 160 PATIENTS WITH EPISODIC MIGRAINE WERE RANDOMLY ASSIGNED TO MEDICAL AND YOGA GROUPS. A TOTAL OF 114 PATIENTS COMPLETED THE TRIAL. BASELINE MEASURES WERE COMPARABLE EXCEPT FOR A HIGHER MEAN HEADACHE FREQUENCY IN THE YOGA GROUP. COMPARED TO MEDICAL THERAPY, THE YOGA GROUP SHOWED A SIGNIFICANT MEAN DELTA VALUE REDUCTION IN HEADACHE FREQUENCY (DELTA DIFFERENCE 3.53 [95% CONFIDENCE INTERVAL 2.52-4.54]; P < 0.0001), HEADACHE INTENSITY (1.31 [0.60-2.01]; P = 0.0004), HIT SCORE (8.0 [4.78-11.22]; P < 0.0001), MIDAS SCORE (7.85 [4.98-10.97]; P < 0.0001), AND PILL COUNT (2.28 [1.06-3.51]; P < 0.0003). CONCLUSION: YOGA AS AN ADD-ON THERAPY IN MIGRAINE IS SUPERIOR TO MEDICAL THERAPY ALONE. IT MAY BE USEFUL TO INTEGRATE A COST-EFFECTIVE AND SAFE INTERVENTION LIKE YOGA INTO THE MANAGEMENT OF MIGRAINE. CLINICALTRIALSGOV IDENTIFIER: CTRI/2017/03/008041. CLASSIFICATION OF EVIDENCE: THIS STUDY PROVIDES CLASS III EVIDENCE THAT FOR PATIENTS WITH EPISODIC MIGRAINE, YOGA AS ADJUVANT TO MEDICAL THERAPY IMPROVES HEADACHE FREQUENCY, INTENSITY, IMPACT, AND DISABILITY. 2020 18 351 44 ASSESSMENT OF SIGNIFICANCE OF YOGA ON QUALITY OF LIFE IN ASTHMA PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: ASTHMA IS A CHRONIC INFLAMMATORY RESPIRATORY DISEASE CHARACTERIZED BY PERIODIC ATTACKS OF WHEEZING, SHORTNESS OF BREATH AND A TIGHT FEELING IN THE CHEST. THE CURRENT STUDY IS BASED ON THE EFFECT OF YOGA ON QUALITY OF LIFE IN ASTHMATICS IN NORTHERN INDIA. MATERIALS AND METHODS: A TOTAL OF 300 PARTICIPANTS OF MILD-TO-MODERATE PERSISTENT ASTHMA (FEV1 >60%) AGED BETWEEN 12 AND 60 YEARS WERE RECRUITED FROM THE DEPARTMENT OF PULMONARY MEDICINE. THEIR QUALITY OF LIFE WAS ASSESSED WITH THE HELP OF MINI ASTHMA QUALITY-OF-LIFE QUESTIONNAIRE (AQLQ) AT BASELINE AND THEN AFTER 3(RD) AND 6(TH) MONTH FROM BASELINE. FORTY-FIVE PARTICIPANTS WERE DROPPED OUT DURING THE STUDY WHILE 255 PARTICIPANTS COMPLETED THE STUDY SUCCESSFULLY. RESULTS: IN "THE YOGA GROUP," SIGNIFICANT IMPROVEMENTS WERE FOUND IN ALL THE SUBDOMAINS OF AQLQ AT 3(RD) MONTH AND AT 6(TH) MONTH IN COMPARISON TO "THE CONTROL GROUP." THE NUMBER NEEDED TO TREAT WAS FOUND TO BE 2.67 FOR THE TOTAL AQLQ SCORE WHICH WAS GREATER THAN THE MINIMAL IMPORTANT DIFFERENCE. CONCLUSION: "THE YOGA GROUP" GOT SIGNIFICANTLY BETTER IMPROVEMENT IN ASTHMA QUALITY-OF-LIFE SCORES THAN "THE CONTROL GROUP." THUS, YOGA CAN BE USED AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF ASTHMA. 2017 19 90 36 A MODIFIED YOGA-BASED EXERCISE PROGRAM IN HEMODIALYSIS PATIENTS: A RANDOMIZED CONTROLLED STUDY. AIM: TO EVALUATE THE EFFECTS OF A YOGA-BASED EXERCISE PROGRAM ON PAIN, FATIGUE, SLEEP DISTURBANCE, AND BIOCHEMICAL MARKERS IN HEMODIALYSIS PATIENTS. MATERIALS AND METHODS: IN 2004 A RANDOMIZED CONTROLLED TRIAL WAS CARRIED OUT IN THE OUTPATIENT HEMODIALYSIS UNIT OF THE NEPHROLOGY DEPARTMENT, ULUDAG UNIVERSITY FACULTY OF MEDICINE. CLINICALLY STABLE HEMODIALYSIS PATIENTS (N=37) WERE INCLUDED AND FOLLOWED IN TWO GROUPS: THE MODIFIED YOGA-BASED EXERCISE GROUP (N=19) AND THE CONTROL GROUP (N=18). YOGA-BASED EXERCISES WERE DONE IN GROUPS FOR 30 MIN/DAY TWICE A WEEK FOR 3 MONTHS. ALL OF THE PATIENTS IN THE YOGA AND CONTROL GROUPS WERE GIVEN AN ACTIVE RANGE OF MOTION EXERCISES TO DO FOR 10 MIN AT HOME. THE MAIN OUTCOME MEASURES WERE PAIN INTENSITY (MEASURED BY THE VISUAL ANALOGUE SCALE, VAS), FATIGUE (VAS), SLEEP DISTURBANCE (VAS), AND GRIP STRENGTH (MMHG); BIOCHEMICAL VARIABLES-- UREA, CREATININE, CALCIUM, ALKALINE PHOSPHATASE, PHOSPHORUS, CHOLESTEROL, HDL-CHOLESTEROL, TRIGLYCERIDE, ERYTHROCYTE, HEMATOCRIT--WERE EVALUATED. RESULTS: AFTER A 12-WEEK INTERVENTION, SIGNIFICANT IMPROVEMENTS WERE SEEN IN THE VARIABLES: PAIN -37%, FATIGUE -55%, SLEEP DISTURBANCE -25%, GRIP STRENGTH +15%, UREA -29%, CREATININE -14%, ALKALINE PHOSPHATASE -15%, CHOLESTEROL -15%, ERYTHROCYTE +11%, AND HEMATOCRIT COUNT +13%; NO SIDE-EFFECTS WERE SEEN. IMPROVEMENT OF THE VARIABLES IN THE YOGA-BASED EXERCISE PROGRAM WAS FOUND TO BE SUPERIOR TO THAT IN THE CONTROL GROUP FOR ALL THE VARIABLES EXCEPT CALCIUM, PHOSPHORUS, HDL-CHOLESTEROL AND TRIGLYCERIDE LEVELS. CONCLUSION: A SIMPLIFIED YOGA-BASED REHABILITATION PROGRAM IS A COMPLEMENTARY, SAFE AND EFFECTIVE CLINICAL TREATMENT MODALITY IN PATIENTS WITH END-STAGE RENAL DISEASE. 2007 20 1423 45 IMPROVEMENT IN NEUROCOGNITIVE FUNCTIONS AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS AND YOGA. CONTEXT AND AIMS: IMPAIRMENT IN COGNITION IS WELL-KNOWN IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. THIS STUDY EXAMINED THE EFFECT OF YOGA THERAPY WITH OR WITHOUT ANTIDEPRESSANTS AND ANTIDEPRESSANTS ALONE ON CERTAIN NEUROPSYCHOLOGICAL FUNCTIONS IN PATIENTS WITH DEPRESSION. CORRELATION BETWEEN CHANGES IN NEUROPSYCHOLOGICAL TEST PERFORMANCE AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS WAS ALSO EXPLORED. MATERIALS AND METHODS: ANTIDEPRESSANT-NAIVE/ANTIDEPRESSANT-FREE OUTPATIENTS WITH DEPRESSION RECEIVED ANTIDEPRESSANT MEDICATION ALONE (N = 23) OR YOGA THERAPY WITH (N = 26) OR WITHOUT (N = 16) ANTIDEPRESSANTS. DEPRESSION WAS ASSESSED USING THE HAMILTON DEPRESSION RATING SCALE. NEUROPSYCHOLOGICAL TESTS INCLUDED DIGIT-SPAN FORWARD AND BACKWARD, REY AUDITORY VERBAL LEARNING TEST, AND TRAIL MAKING TESTS (TMT-A AND B). THESE TESTS WERE ADMINISTERED BEFORE AND 3 MONTHS AFTER THE TREATMENT IN PATIENTS, AND ONCE IN HEALTHY COMPARISON SUBJECTS (N = 19). STATISTICAL ANALYSIS: BASELINE DIFFERENCES WERE ANALYZED USING INDEPENDENT SAMPLE T-TEST, CHI-SQUARE, AND ONE-WAY ANOVA. PAIRED T-TEST WAS USED TO ANALYZE THE CHANGE FROM BASELINE TO FOLLOW-UP. PEARSON'S CORRELATION WAS USED TO EXPLORE THE ASSOCIATION OF CHANGE BETWEEN 2 VARIABLES. RESULTS: PATIENTS HAD IMPAIRED PERFORMANCE ON MOST NEUROPSYCHOLOGICAL TESTS. AFTER 3 MONTHS, THERE WAS SIGNIFICANT IMPROVEMENT - PATIENTS' PERFORMANCE WAS COMPARABLE TO THAT OF HEALTHY CONTROLS ON MAJORITY OF THE TESTS. SIGNIFICANT INVERSE CORRELATION WAS OBSERVED BETWEEN INCREASE IN BDNF LEVELS AND IMPROVEMENT IN TMT "A" DURATION IN YOGA-ALONE GROUP (R = -0.647; P = 0.009). CONCLUSIONS: TO CONCLUDE THAT, YOGA THERAPY, ALONE OR IN COMBINATION WITH MEDICATIONS, IS ASSOCIATED WITH IMPROVED NEUROPSYCHOLOGICAL FUNCTIONS AND NEUROPLASTIC EFFECTS IN PATIENTS WITH DEPRESSION. 2018